Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study

Academic Article
Publication Date:
2022
Iris type:
1.1 Articolo in rivista
Keywords:
Fusion Proteins, bcr-abl; Humans; Protein Kinase Inhibitors; Precursor Cell Lymphoblastic Leukemia-Lymphoma
List of contributors:
Authors of the University:
Handle:
https://iris.unisr.it/handle/20.500.11768/132832
Published in:
BONE MARROW TRANSPLANTATION
Journal